Privacy preserving validation for multiomic prediction models.

Reproducibility of results obtained using ribonucleic acid (RNA) data across labs remains a major hurdle in cancer research. Often, molecular predictors trained on one dataset cannot be applied to another due to differences in RNA library preparation and quantification, which inhibits the validation of predictors across labs. While current RNA correction algorithms reduce these differences, they require simultaneous access to patient-level data from all datasets, which necessitates the sharing of training data for predictors when sharing predictors. Here, we describe SpinAdapt, an unsupervised RNA correction algorithm that enables the transfer of molecular models without requiring access to patient-level data. It computes data corrections only via aggregate statistics of each dataset, thereby maintaining patient data privacy. Despite an inherent trade-off between privacy and performance, SpinAdapt outperforms current correction methods, like Seurat and ComBat, on publicly available cancer studies, including TCGA and ICGC. Furthermore, SpinAdapt can correct new samples, thereby enabling unbiased evaluation on validation cohorts. We expect this novel correction paradigm to enhance research reproducibility and to preserve patient privacy.

Aquaporins; systemic, functional and therapeutic correlations in health and disease.

Aquaporins are transcellular proteins that majorly consist of a tetrametric hour-glass-like structure. Aquaporins have a definitive function in transpositioning of water and solutes across cell membranes. The current review was planned to provide information regarding structure, expression and functions of aquaporins in the human body, and to generate a comprehensive summary of physiological and pathophysiological correlations related to aquaporins and their therapeutic implications. Absence or mutations of different aquaporins are believed to be linked to clinical diseases, including Sjogren's syndrome, nephrogenic diabetes insipidus, liver dysfunction and obesity. Modern therapeutic techniques are utilising aquaporins in gene therapy for Sjogren's syndrome and cholestasis. The narrative review aims at providing a comprehensive description of localisation, function, abnormal clinical conditions and therapeutic implications of aquaporin proteins.

Fe3O4 supported [Cu(ii)(met)(pro-H)2] complex as a novel nanomagnetic catalytic system for room temperature C-O coupling reactions.

In this study, a newly-designed copper(ii) complex of metformin and l-proline which was immobilized on Fe3O4 MNPs was developed. The structure of the catalyst platform was fully characterized using spectroscopic analyses. Moreover, the catalytic activity of [Fe3O4@Cu(ii)(Met)(Pro-H)2] was investigated in a one-pot synthesis of a variety of functionalized ethers in reasonable to excellent yields through Ullman reaction in an aqueous environment using various aryl halides, phenol, and Cs2CO3 and without using any external Cu-reducing agents. Notably, gentle catalytic conditions, quick reaction times, applicability, low cost, and preventing dangerous chemicals and solvents during synthesis and catalytic application are some of the superior properties of the [Fe3O4@Cu(ii)(Met)(Pro-H)2] complex. Furthermore, the catalyst can be reused for several runs (at least eight times) without remarkable loss in efficiency.